Literature DB >> 3876768

Severe deficiency of alpha 1-antitrypsin associated with cutaneous vasculitis, rapidly progressive glomerulonephritis, and colitis.

M Lewis, J Kallenbach, M Zaltzman, H Levy, D Lurie, R Baynes, P King, A Meyers.   

Abstract

The association of vasculitis with severe deficiency of alpha 1-antitrypsin is rare. This report describes a 44-year-old man with severe deficiency of alpha 1-antitrypsin associated with diffuse vasculitis involving skin, kidney (rapidly progressive glomerulonephritis), and colon (colitis). Colitis has not previously been reported in association with deficiency of alpha 1-antitrypsin. Other reported cases are reviewed and the possible immunologic mechanisms underlying the association are discussed.

Entities:  

Mesh:

Year:  1985        PMID: 3876768     DOI: 10.1016/0002-9343(85)90036-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency.

Authors:  E J Campbell; M A Campbell; S S Boukedes; C A Owen
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Examination of the molecular diversity of alpha1 antitrypsin in urine: deficit of an alpha1 globulin fraction on cellulose acetate membrane electrophoresis.

Authors:  Ryoko Machii; Minoru Sakatume; Ryo Kubota; Shizuko Kobayashi; Fumitake Gejyo; Kiyoko Shiba
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

3.  Glomerulonephritis as late manifestation of severe alpha 1-antitrypsin deficiency.

Authors:  R E Stauber; J H Horina; M Trauner; G J Krejs; M Ratschek; M Klimpfinger
Journal:  Clin Investig       Date:  1994-05

4.  Three cases of alpha-1-antitrypsin deficiency in the elderly.

Authors:  C I Jack; C C Evans
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

5.  Amelioration of immune complex-mediated glomerulonephritis by synthetic protease inhibitors.

Authors:  J C Jennette; R R Tidwell; J D Geratz; D H Bing; R J Falk
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

6.  Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis.

Authors:  J A Savige; L Chang; L Cook; J Burdon; M Daskalakis; J Doery
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

7.  The prevalence of alpha-1 antitrypsin deficiency in Ireland.

Authors:  Tomás P Carroll; Catherine A O'Connor; Olwen Floyd; Joseph McPartlin; Dermot P Kelleher; Geraldine O'Brien; Borislav D Dimitrov; Valerie B Morris; Clifford C Taggart; Noel G McElvaney
Journal:  Respir Res       Date:  2011-07-13

8.  Identification and characterisation of eight novel SERPINA1 Null mutations.

Authors:  Ilaria Ferrarotti; Tomás P Carroll; Stefania Ottaviani; Anna M Fra; Geraldine O'Brien; Kevin Molloy; Luciano Corda; Daniela Medicina; David R Curran; Noel G McElvaney; Maurizio Luisetti
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

9.  Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015.

Authors:  Timm Greulich; Christoph Nell; Christian Herr; Claus Vogelmeier; Viktor Kotke; Stefan Wiedmann; Marion Wencker; Robert Bals; Andreas Rembert Koczulla
Journal:  Orphanet J Rare Dis       Date:  2016-06-10       Impact factor: 4.123

10.  An RNA structure-mediated, posttranscriptional model of human α-1-antitrypsin expression.

Authors:  Meredith Corley; Amanda Solem; Gabriela Phillips; Lela Lackey; Benjamin Ziehr; Heather A Vincent; Anthony M Mustoe; Silvia B V Ramos; Kevin M Weeks; Nathaniel J Moorman; Alain Laederach
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.